BEL 20 closes at 5,840.260, up 0.42 percent

The BEL 20 ended Thursday's session in positive territory, extending the recovery in Brussels. The index closed at 5,840.260 on October 29, 2026, up 24.630 points, or 0.42 percent, from the previous close of 5,815.630. The close was recorded at 18:05 CET by Bolsamania. The Euronext Brussels index page identifies the benchmark under ISIN BE0389555039 and lists the previous close at 5,815.630.

Healthcare and industrials provide support

The session's advance was broad enough to lift the index to a new one-month high. According to Investing.com, healthcare, industrial and utility sectors were among the strongest parts of the Brussels market. Advancing shares outnumbered declining shares 52 to 35, while 14 stocks finished unchanged. That breadth indicates that the day's gain was not limited to a single component, although the index's performance remained uneven across sectors and companies.

UCB leads the gainers

Healthcare company UCB was the strongest BEL 20 performer listed in the close report, rising 3.51 percent to 280.00 euros. Aperam gained 2.01 percent to 35.46 euros, while Syensqo advanced 1.11 percent to 77.35 euros. Other positive contributors included Argenx, Elia Group, Sofina and Groupe Bruxelles Lambert. The individual share moves provide context for the index result, but they do not by themselves establish a single cause for the benchmark's performance.

AB InBev remains a drag

Anheuser-Busch InBev was the weakest of the highlighted BEL 20 constituents, falling 3.23 percent to 70.68 euros. Montea declined 0.92 percent to 64.80 euros and Azelis lost 0.85 percent to 11.66 euros. The contrast between UCB's advance and AB InBev's decline underlines the divergent contribution of large index members during the session. For investors, the 0.42 percent gain therefore combines a positive sector backdrop with notable dispersion among individual components.

Further index coverage is available on the BEL 20 topic page.